Praxis Medical Insights

Immediate Recognition and Differentiation

The American College of Critical Care Medicine recommends immediate recognition of TRALI, characterized by acute hypoxemia and respiratory distress, bilateral pulmonary infiltrates on chest radiograph, fever, and dyspnea, in the absence of circulatory overload signs, within 6 hours of platelet transfusion 1, 2, 3
The presence of bilateral pulmonary infiltrates on chest radiograph and the absence of circulatory overload signs distinguish TRALI from Transfusion-Associated Circulatory Overload (TACO) 1, 2, 3

The American Thoracic Society recommends stopping the transfusion immediately and maintaining IV access with normal saline, administering high-flow oxygen to address hypoxemia, and monitoring vital signs every 5-15 minutes 3
The Society of Critical Care Medicine suggests providing lung-protective mechanical ventilation if intubation is required, maintaining appropriate fluid balance without overhydration, and avoiding diuretics, which are ineffective for TRALI and may worsen the condition 1, 2

The American Association for Clinical Chemistry recommends sending baseline labs immediately, including complete blood count, PT, aPTT, Clauss fibrinogen, direct antiglobulin test (DAT), and repeat cross-match, to rule out bacterial contamination and other transfusion-related complications 3
The Infectious Diseases Society of America suggests obtaining blood cultures from both patient and blood product to rule out bacterial contamination 1

The American Association of Blood Banks recommends reporting every suspected case of TRALI to the local blood bank immediately, as TRALI is underdiagnosed and underreported despite being a leading cause of transfusion-related mortality 2, 3

The American Physiological Society explains that the mechanism of TRALI involves donor leukocyte antibodies interacting with recipient neutrophils, causing non-cardiogenic pulmonary edema, and that platelet concentrates are among the blood products most frequently implicated in TRALI 1, 2, 3

The American Red Cross recommends screening donors for leukocyte antibodies, preferential use of male-only plasma donors, universal leukoreduction of blood products, and pathogen reduction technologies when available, to mitigate the risk of TRALI 1, 2, 3

The Infectious Diseases Society of America recommends considering bacterial contamination and initiating empiric antibiotics in patients who experience severe febrile reactions during or shortly after platelet transfusion, particularly in neutropenic recipients 1
The Society of Critical Care Medicine suggests avoiding continuous thermodilution-based and pulse contour analysis-based cardiac output monitoring in patients requiring advanced support, as these may provide erroneous results 4